- Previous Close
0.0000 - Open
0.8950 - Bid 0.7025 x --
- Ask 0.8950 x 40000
- Day's Range
0.8150 - 0.8950 - 52 Week Range
0.4100 - 1.9400 - Volume
2,460 - Avg. Volume
3,218 - Market Cap (intraday)
12.169M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0900 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
U.S. NeuroSurgical Holdings, Inc., through its subsidiaries, owns and operates stereotactic radiosurgery centers that utilize gamma knife technology. The company's gamma knife is a stereotactic radio surgical device used to treat brain tumors and other malformations of the brain without invasive surgery. U.S. NeuroSurgical Holdings, Inc. was founded in 1993 and is based in Rockville, Maryland.
www.usneuro.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: USNU
View MorePerformance Overview: USNU
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: USNU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: USNU
View MoreValuation Measures
Market Cap
12.17M
Enterprise Value
9.06M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
3.32
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-39.72%
Return on Equity (ttm)
-85.22%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-2.06M
Diluted EPS (ttm)
-0.0900
Balance Sheet and Cash Flow
Total Cash (mrq)
4.03M
Total Debt/Equity (mrq)
1.72%
Levered Free Cash Flow (ttm)
-1.78M